Endocrinology

In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...

Samiya Khan, MD, examines the national impact of social isolation on diabetes prevalence and glycemic control in aging populations, presenting key findings from a cross-sectional study at ENDO 2025, July...

The team behind SMART, an AI-powered web application for diabetic retinopathy detection, discusses the development, validation, and clinical relevance of a lightweight, privacy-conscious screening model...

In this expert conversation, David S. Cooper MD, professor of medicine and radiology at the Johns Hopkins University School of Medicine, explores how antithyroid medications, particularly methimazole,...

Laura Davisson, MD, MPH, FACP, professor of medicine, West Virginia University, discusses the rapidly evolving pharmacologic landscape for obesity management, including practical strategies for handling...

In part 2 of this interview, Estelle Everett, MD, addresses the shortage of endocrinologists from underserved communities and highlights strategies to build a more diverse health care workforce. She also...

Diabetes technology has improved significantly in recent years, including the use of blood glucose meters, continuous glucose monitors (CGM), cutting-edge insulin pumps, and more. Lisa Jones, MA, RDN, LND,...

In this interview, Lisa Jones MA, RDN, LND, FAND talks to Rachel Stahl Salzman, MS, RDN, CDN, CDCES, about possible misconceptions about digital health devices in the management of patients with diabetes,...

In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.

Jonathon O. Russell, MD, answers our questions about his new study, which found that magnesium disorders may be a modifiable target in reducing the incidence of hypocalcemia after total thyroidectomy.